Skip to main content
. 2019 Apr 30;35(2):100–106. doi: 10.3393/ac.2018.10.01

Table 2.

Descriptive analysis of pCR-related factors

Variable pCR (n = 29) Non-pCR (n = 111) P-value
Men 19 (65.5) 74 (66.7) 1
Age (yr) 60.0 (55.0–68.0) 65.0 (55.5–72.0) 0.385
CEA (ng/mL) 2.4 (1.8–3.6) 4.1 (2.2–7.4) 0.008
Pre-nCRT NLR 1.8 (1.5–2.6) 2.1 (1.7–3.0) 0.042
Post-nCRT NLR 3.0 (2.5–3.8) 3.7 (2.6–4.9) 0.093
Delay after RT (wk) 7.0 (6.0–7.0) 7.0 (6.0–7.0) 0.641
Tumor differentiation 1
 Well/moderate 28 (96.6) 105 (94.6)
 Poor/mucinous 1 (3.4) 6 (5.4)
cT4, yes 0 (0) 12 (10.8) 0.139
cN1, yes 17 (58.6) 96 (86.5) 0.002
Tumor location 1
 RA 4 (13.8) 17 (15.3)
 RB 25 (86.2) 94 (84.7)
Perforation, yes 0 (0) 3 (2.7) 0.861
Obstruction, yes 1 (3.4) 10 (9.0) 0.546
Pre-nCRT NLR > 2.77 4 (13.8) 40 (36.0) 0.038
Post-nCRT NLR > 3.23 11 (37.9) 69 (62.2) 0.033

Values are presented as number (%) or median (interquartile range).

pCR, pathologic complete response; CEA, carcinoembryonic antigen; nCRT, neoadjuvant chemoradiation therapy; NLR, neutrophil to lymphocyte ratio; RT, radiotherapy; RA, above peritoneal reflection; RB, below peritoneal reflection.